1989
DOI: 10.1016/0005-2760(89)90137-9
|View full text |Cite
|
Sign up to set email alerts
|

Control of lipoprotein lipase secretion in mouse macrophages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

1990
1990
2014
2014

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 41 publications
0
6
0
Order By: Relevance
“…In 3T3-L1 and in ob/ob cells lipoprotein lipase synthesis is turned on after the cells become confluent and differentiate into adipocyte-like cells [8,12]. In macrophages, on the other hand, lipoprotein lipase production is high in activated [7] and proliferating [6] cells; when the cells become growth-arrested, lipoprotein lipase production is remarkably suppressed. The constitutive expression of lipoprotein lipase in CHO cells may reflect a property in the ancestral ovarian cells.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In 3T3-L1 and in ob/ob cells lipoprotein lipase synthesis is turned on after the cells become confluent and differentiate into adipocyte-like cells [8,12]. In macrophages, on the other hand, lipoprotein lipase production is high in activated [7] and proliferating [6] cells; when the cells become growth-arrested, lipoprotein lipase production is remarkably suppressed. The constitutive expression of lipoprotein lipase in CHO cells may reflect a property in the ancestral ovarian cells.…”
Section: Discussionmentioning
confidence: 99%
“…Many studies on lipoprotein lipase have been carried out with cell lines [8][9][10][11][12][13] and with primary cultures of cells [14][15][16][17][18][19]. In the cell lines the expression of lipoprotein lipase is usually dependent on the growth conditions [6][7][8]12]. In the present paper we report that the enzyme is also produced in Chinese-hamster ovary (CHO) cells, where it is expressed both in growing and in confluent cells.…”
Section: Introductionmentioning
confidence: 96%
See 1 more Smart Citation
“…This experiment uniquely uses both VLDL and macrophages from rat sources and to our knowledge is the first study to compare macrophage utilisation of NEFA and TAG (VLDL), in both quiescent and active state. In the unstimulated (control) state, cVLDL-TAG was utilised to a similar extent as NEFA by 48h of incubation (VLDL-TAG utilisation rate peaked at 24-36h (data not shown) but this probably reflects alterations in substrate utilisation between glucose and lipids during rapid growth phase [16]). However, TAG from VLDL synthesised by endotoxic rat liver (eVLDL) was utilised at a greater rate than NEFA or cVLDL-TAG, suggesting that eVLDL is a better substrate for macrophages and apparently supporting similar findings of eVLDL efficacy in heart [8].…”
Section: Discussionmentioning
confidence: 99%
“…39 Lipopolysaccharide also suppresses LPL secretion from macrophages. 40 On the other hand, it has been reported that cholesterol-rich lipoproteins, 12 hypertriglyceridemic very low density lipoproteins, 13 and L-cell-conditioned medium 41 enhance LPL secretion from macrophages. L-cell-conditioned medium, which stimulates the macrophage lineage, increases LPL secretion from mouse bone marrow macrophages and thioglycollate-elicited peritoneal macrophages, whereas it has no effect on LPL secretion from resident peritoneal macrophages.…”
Section: Discussionmentioning
confidence: 99%